Home › Funds › HUSSMAN STRATEGIC ADVISORS, INC. › NUTX

HUSSMAN STRATEGIC ADVISORS, INC. position in NUTX

NUTEX HEALTH INC · Consumer Discretionary

HUSSMAN STRATEGIC ADVISORS, INC. reported holding 21,000 shares of NUTX (NUTEX HEALTH INC) in its Q3 2026 13F filing — a position valued at US$4.4M, representing 0.95% of its reported portfolio and ranking #7 among its reported holdings. HUSSMAN STRATEGIC ADVISORS, INC. has disclosed NUTX holdings in 3 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)21.00K sh
Reported value held$4.44M
Portfolio Weight0.95%
First reportedQ4 2025
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How HUSSMAN STRATEGIC ADVISORS, INC.'s NUTX position evolved

HUSSMAN STRATEGIC ADVISORS, INC. first disclosed a stake in NUTX in Q4 2025 at 21,000 shares (US$3.5M). The position peaked in Q3 2026 at 21,000 shares, worth US$4.4M. Across 3 filings, HUSSMAN STRATEGIC ADVISORS, INC. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 21,000 shares valued at US$4.4M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 21.00K $3.46M New
Q1 2026 21.00K $2.00M Hold
Q3 2026 21.00K $4.44M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NUTX and 13F data

NUTX (NUTEX HEALTH INC) is a Consumer Discretionary company. 79 other funds we track also report a position in NUTX — the largest reported positions include Pertento Partners LLP (US$109.9M), WINMILL & CO. INC (US$13.8M), ONE PLUS ONE WEALTH MANAGEMENT, LLC (US$8.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NUTX

All NUTX fund holders →

FAQ

How long has HUSSMAN STRATEGIC ADVISORS, INC. held NUTX?

HUSSMAN STRATEGIC ADVISORS, INC. has disclosed NUTX holdings in 3 of the last 4 reported quarters, going back to Q4 2025.

What is HUSSMAN STRATEGIC ADVISORS, INC.'s current position in NUTX?

As of Q3 2026, HUSSMAN STRATEGIC ADVISORS, INC. holds 21.00K shares of NUTX (NUTEX HEALTH INC), valued at $4.44M, representing 0.95% of its reported portfolio and ranking #7.

Has HUSSMAN STRATEGIC ADVISORS, INC. been buying or selling NUTX?

In the latest 13F filing (Q3 2026), HUSSMAN STRATEGIC ADVISORS, INC. newly opened its position in NUTX. The position peaked in Q3 2026 at 21.00K shares.

Which other funds hold NUTX?

Other major institutional holders of NUTX include Pertento Partners LLP, WINMILL & CO. INC, ONE PLUS ONE WEALTH MANAGEMENT, LLC, among 79 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.